A Bittersweet Pill To Swallow
I hate goodbyes. So, rather than get all sappy and sentimental, I'm just gonna say, "Thank you."
Thank you to CNBC President Mark Hoffman for hiring me.
Thank you so much Jack Grubmanfor walking out your front door and opening your mouth on that June morning back in 2002.
Thank you CNBC management for giving me the drug beat.
Thanks to analysts like Dr. Mark Monane, Mike King, Barbara Ryan, Dr. Len Yaffe, Mike Weinstein, David Kliff and so many others for helping me find my way on the beat.
Thank you to the then "Wall Street Journal" health care team for walking me back at lunch that day when I was a pharma cubbie and explaining the difference between phase 1, 2 and 3 of clinical trials.
Thanks to Dendreon , the FDA and all of the Dendreonians for providing such rich material, grist and Dendrama to a reporter who eats that stuff up.
A thousand thank-yous to my producer, Ruth, for helping me get on the air, for elevating our coverage to a whole nutha level and getting me access to key people and places.
Thanks to my dear old dad, Howard, for keeping his TV locked on CNBC for the last 10 years. It's okay to change the channel now. Well...actually...on second thought, don't do that!
Thank you to my partner, John, for being my sounding board, proofreader, joke writer and best friend. He even helped me write this blog.
And last, but not least, thanks to all of you for watching my reports, reading my blogand following my tweets.
Like Dorothy said to Scarecrow, "I think I'm going to miss you most of all."
Editor's Note: Mike's last day with CNBC will be Friday, May 7. We wish him the best of luck. He will be missed.
Questions? Comments? Pharma@cnbc.com and follow me on Twitter at mhuckman t